Royalty Pharma

PE firm investing in marketed and late stage biopharmaceutical companies

placeNew York City, New York, United States calendar_todayFounded 1996 groups75 employees language royaltypharma.com

Registered entities

Innovation

7 patent families (5 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace dormant. Cited 21 times.

YearFilings
20122
20135
20143
20151
20163
20173
20201

Social engagement

Social engagement: 9.6K social following, 6 posts in the last 12 months — above the industry median.

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital467%
Private equity233%

Recent activity

18 Mar 2026
Leadership hire
Executive Vice President, Partnering & Investments
3 Mar 2026
Leadership hire
Senior Vice President and Head of Asia
Coming soon